Charles River Laboratories Intl. Inc (NYSE:CRL) Insider Trading Activity – Director Sold 4,540 shares of Stock

ME Staff
-
0

Insider Trading Activity For Charles River Laboratories Intl. Inc (NYSE:CRL)

Stephen D Chubb , Director of Charles River Laboratories Intl. Inc (NYSE:CRL) reportedly Sold 4,540 shares of the company’s stock at an average price of 141.23 for a total transaction amount of $641,184.20 SEC Form

Insider Trading History For Charles River Laboratories Intl. Inc (NYSE:CRL)

  • On 3/13/2013 David P Johst, VP, sold 17,038 with an average share price of $45.00 per share and the total transaction amounting to $766,710.00.
  • On 5/10/2013 George Massaro, Director, sold 2,020 with an average share price of $44.09 per share and the total transaction amounting to $89,061.80.
  • On 5/14/2013 James C Foster, CEO, sold 113,810 with an average share price of $45.00 per share and the total transaction amounting to $5,121,450.00.
  • On 6/3/2013 Thomas F Ackerman, CFO, sold 4,000 with an average share price of $42.40 per share and the total transaction amounting to $169,600.00.
  • On 8/2/2013 Thomas Ackerman, CFO, sold 26,250 with an average share price of $46.03 per share and the total transaction amounting to $1,208,287.50.
  • On 8/2/2013 Deborah Turner Kochevar, Director, sold 4,447 with an average share price of $46.02 per share and the total transaction amounting to $204,650.94.
  • On 8/2/2013 Davide Molho, VP, sold 4,100 with an average share price of $45.89 per share and the total transaction amounting to $188,149.00.

    • Analyst Ratings History For Charles River Laboratories Intl. Inc (NYSE:CRL)

    • On 6/28/2017 Citigroup Reiterated Rating Neutral with a price target of $91.00 to $104.00
    • On 1/18/2018 Evercore ISI Initiated Coverage of rating In to In-Line with a price target of $117.00
    • On 2/14/2018 JPMorgan Chase & Co. Boost Price Target of rating Overweight to Overweight with a price target of $110.00 to $120.00
    • On 4/20/2018 Mitsubishi UFJ Financial Group Initiated Coverage of rating Neutral with a price target of $115.00
    • On 6/15/2018 KeyCorp Upgraded rating Sector Weight to Overweight with a price target of $115.85 to $130.00
    • On 7/16/2018 Bank of America Boost Price Target of rating Buy to Buy with a price target of $120.00 to $125.00
    • On 8/27/2018 Argus Boost Price Target of rating Buy to Buy with a price target of $125.00 to $140.00

    Recent Trading Activity for Charles River Laboratories Intl. Inc (NYSE:CRL)
    Shares of Charles River Laboratories Intl. Inc closed the previous trading session at with 142.24 shares trading hands.